Jennifer Adelsperger

Author

Howard Hughes Medical Institute

Also Known As

Jennifer Adelsperger

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Howard Hughes Medical Institute Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University Emory University

About

Jennifer Adelsperger is an author at Howard Hughes Medical Institute specializing in cell biology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	3.3K
2	Cell Biology	3	3	3.3K
3	Pathology	2	2	3.1K
4	Cell Signaling	1	1	3K
5	Hematology	1	1	3K

Jennifer Adelsperger

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Ross L. Levine, Martha Wadleigh, Jan Cools, Cancer Cell Hematological MalignancyPolycythemia VeraEssential ThrombocythemiaReceptor Tyrosine KinaseMalignant Blood Disorder	2005	3K
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype Joseph D. Growney, Hirokazu Shigematsu, Zhe Li, Blood	2005	448
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412 Joseph D. Growney, Jennifer Clark, Jennifer Adelsperger, Blood	2005	249
FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic Leukemia Benjamin H. Lee, Zuzana Tóthová, Ross L. Levine, Cancer Cell Hematological MalignancyRadiation OncologyChronic Myelomonocytic LeukemiaMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2007	222
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder Jing Chen, Daniel J. DeAngelo, Jeffery L. Kutok, Proceedings of the National Academy of Sciences	2004	172
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies Jing Chen, Benjamin H. Lee, Ifor R. Williams, Oncogene Hematopoietic MalignanciesHematological MalignancyMedicineMalignant Blood DisorderPathology	2005	91
Loss of Runx1 Perturbs Adult Hematopoiesis and Is Associated with a Myeloproliferative Phenotype. Joseph D. Growney, Hirokazu Shigematsu, Zhe Li, Blood	2004	13

Page 1